Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AddLife AB Class B (ADDLF)
:ADDLF
Holding ADDLF?
Track your performance easily
Earnings Data
Report Date
Feb 05, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.13Last Year’s EPS
0.1Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 12, 2019
|% Change Since: -17.33%
|Next Earnings Date:Nov 07, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with stable organic growth and positive developments such as the acquisition of BonsaiLab and improved Medtech margins. However, challenges in the Labtech segment and key markets, as well as currency impacts, were notable concerns.Company Guidance
In the third quarter of 2024, AddLife reported a 3% organic and currency-adjusted growth, maintaining a stable EBITA margin of 9.8%, despite the typically slower summer months. The company's Labtech segment experienced a slight decline in instrument sales, although consumable sales remained stable. In contrast, the Medtech segment also recorded a 3% growth, driven by higher-margin product sales and ongoing profitability improvement initiatives. Operational cash flow was stable, with a focus on inventory reduction and working capital efficiency, despite a SEK 73 million negative impact from decreased accounts payables. The acquisition of BonsaiLab contributed to the group's positive performance, bringing strong market conditions and healthy margins. Net debt remained unchanged, supported by favorable foreign exchange impacts, maintaining a leverage ratio of 3.6. The company remains committed to its established priorities of enhancing profit margins, organic growth, and strategic acquisitions while anticipating a seasonally stronger fourth quarter.Organic Growth
The company achieved a 3% organic growth in both Labtech and Medtech segments.
Stable Cash Flow
Operating cash flow remained stable compared to last year, with improved cash conversion due to focus on inventory reduction and working capital efficiency.
Acquisition of BonsaiLab
The acquisition of BonsaiLab, a leading Spanish distributor in cell and molecular biology, was completed, contributing positively to the company's growth.
Medtech Margin Improvement
The EBITA margin in the Medtech segment increased by 7%, reaching 10.7% compared to 10% in the previous year.
Profitability Improvement Initiatives
The profitability improvement initiatives, including the closure of Camanio, are progressing according to plan, resulting in significant cost savings.
---
ADDLF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ADDLF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 23, 2024 | $15.12 | $13.68 | -9.52% |
| Jul 15, 2024 | $13.72 | $14.10 | +2.77% |
| Apr 24, 2024 | $9.17 | $9.67 | +5.45% |
| Feb 02, 2024 | $10.79 | $10.66 | -1.20% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does AddLife AB Class B (ADDLF) report earnings?
AddLife AB Class B (ADDLF) is schdueled to report earning on Feb 05, 2025, TBA Not Confirmed.
What is AddLife AB Class B (ADDLF) earnings time?
AddLife AB Class B (ADDLF) earnings time is at Feb 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ADDLF EPS forecast?
ADDLF EPS forecast for the fiscal quarter 2024 (Q4) is 0.13.
---